Press Release Annexon Appoints Renowned Retinal Surgeon and Biotechnology Entrepreneur Mark S. Blumenkranz, M.D., M.M.S. to its Board of Directors 10 hours ago
Press Release Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week Aug 6
Press Release Annexon Secures Strategic Credit Facility for up to $200 Million from Oxford Finance Jul 30